Palo Alto Investors LP Long-Term Concentrated

Location: Palo Alto, CA

CIK: 0001306923 · Show all filings

Period: Q1 2017 (← Previous) (Next →)

Filing Date: May 15, 2017

Total Value: $2.116B (100.0% shares, 0.0% debt)

Holdings (39)

UTHR UNITED THERAPEUTICS CORP DEL 12.1%
Value $255M Shares 1,883,315 Est. Cost $88.34 Unrealized +71.5%
CLOVIS ONCOLOGY INC 11.7%
Value $248M Shares 3,894,963 Est. Cost $54.10 Unrealized
ABIOMED INC 11.4%
Value $241M Shares 1,921,484 Est. Cost $30.32 Unrealized
BMRN BIOMARIN PHARMACEUTICAL INC 9.9%
Value $209M Shares 2,382,619 Est. Cost $79.29 Unrealized +12.2%
ALEXION PHARMACEUTICALS INC 5.9%
Value $125M Shares 1,027,060 Est. Cost $120.21 Unrealized
ZELTIQ AESTHETICS INC 5.3%
Value $113M Shares 2,032,692 Est. Cost $33.92 Unrealized
INSM INSMED INC 4.6%
Value $96.9M Shares 5,534,150 Est. Cost $14.57 Unrealized +5.8%
EPIZYME INC 3.9%
Value $82.17M Shares 4,791,051 Est. Cost $14.80 Unrealized
WRIGHT MED GROUP N V 3.9%
Value $81.79M Shares 2,628,193 Est. Cost $23.37 Unrealized
SAGE THERAPEUTICS INC 3.7%
Value $78.32M Shares 1,101,951 Est. Cost $42.59 Unrealized
AMAG PHARMACEUTICALS INC 3.6%
Value $75.42M Shares 3,344,620 Est. Cost $29.94 Unrealized
PRTA PROTHENA CORP PLC 2.8%
Value $58.91M Shares 1,055,855 Est. Cost $32.05 Unrealized +63.9%
VNDA VANDA PHARMACEUTICALS INC 2.8%
Value $58.85M Shares 4,203,270 Est. Cost $8.70 Unrealized +63.7%
FOLD AMICUS THERAPEUTICS INC 2.7%
Value $56.21M Shares 7,882,988 Est. Cost $6.23 Unrealized +1.4%
ACAD ACADIA PHARMACEUTICALS INC 2.6%
Value $54.68M Shares 1,590,430 Est. Cost $29.78 Unrealized +18.5%
KARYOPHARM THERAPEUTICS INC 2.1%
Value $43.74M Shares 3,406,475 Est. Cost $19.89 Unrealized
CELGENE CORP 1.7%
Value $36.74M Shares 295,240 Est. Cost $97.51 Unrealized
STAA STAAR SURGICAL CO 1.6%
Value $34.04M Shares 3,473,170 Est. Cost $7.97 Unrealized +25.1%
ALGN ALIGN TECHNOLOGY INC 1.2%
Value $25.59M Shares 223,107 Est. Cost $94.04 Unrealized +7.4%
AIMMUNE THERAPEUTICS INC 1.2%
Value $25.5M Shares 1,173,498 Est. Cost $22.42 Unrealized
GILD GILEAD SCIENCES INC 1.1%
Value $23.88M Shares 351,600 Est. Cost $62.02 Unrealized -18.3%
MOMENTA PHARMACEUTICALS INC 1.1%
Value $23.49M Shares 1,759,376 Est. Cost $14.08 Unrealized
SHIRE PLC 1.1%
Value $22.68M Shares 130,200 Est. Cost $219.26 Unrealized
RIGEL PHARMACEUTICALS INC 0.7%
Value $14.08M Shares 4,254,623 Est. Cost $3.39 Unrealized
EXAS EXACT SCIENCES CORP 0.5%
Value $10.04M Shares 425,276 Est. Cost $13.30 Unrealized +49.0%
SUNESIS PHARMACEUTICALS INC 0.2%
Value $4.766M Shares 1,162,473 Est. Cost $4.37 Unrealized
ALIMERA SCIENCES INC 0.2%
Value $4.219M Shares 3,013,793 Est. Cost $4.88 Unrealized
ACELRX PHARMACEUTICALS INC 0.2%
Value $3.253M Shares 1,032,715 Est. Cost $5.54 Unrealized
DICERNA PHARMACEUTICALS INC 0.1%
Value $1.637M Shares 481,519 Est. Cost $5.48 Unrealized
CYTK CYTOKINETICS INC 0.1%
Value $1.589M Shares 123,686 Est. Cost $6.71 Unrealized +74.1%
IDERA PHARMACEUTICALS INC 0.1%
Value $1.522M Shares 616,355 Est. Cost $3.70 Unrealized
CEMPRA INC 0.1%
Value $1.276M Shares 340,320 Est. Cost $22.71 Unrealized
Trevena Inc 0.1%
Value $1.253M Shares 341,300 Est. Cost $3.67 Unrealized
INTREXON CORP 0.0%
Value $830K Shares 41,900 Est. Cost $28.82 Unrealized
SOPHIRIS BIO INC 0.0%
Value $699K Shares 247,000 Est. Cost $2.60 Unrealized
HISTOGENICS CORP 0.0%
Value $524K Shares 302,922 Est. Cost $11.00 Unrealized
ZOGENIX INC 0.0%
Value $320K Shares 29,500 Est. Cost $13.36 Unrealized
ALCOBRA LTD 0.0%
Value $311K Shares 272,788 Est. Cost $5.98 Unrealized
CAPNIA INC 0.0%
Value $301K Shares 423,738 Est. Cost $0.71 Unrealized